Beitou Health Management Hospital · Taipei · District hospital

High Precision Medical Imaging Health Checkup (Sanitas Elite Premier)

Name: High Precision Medical Imaging Health Checkup (Sanitas Elite Premier)
Brand: Beitou Health Management Hospital
Price: 235041 TWD
Availability: InStock

US$7,322

NT$235,041 · you pay the hospital in NT$

The hospital says foreign-national pricing may differ; ask the hospital to confirm the price, or we confirm it in Book it for me.

Book this checkup

Prefer to book it yourself? Call Beitou Health Management Hospital on 0800-015-104 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Abdominal MRI / MRCP, Breast MRI, Head and neck MRI, Pelvic MRI and Whole spine MRI and a 77-test panel.

English report

Ask the hospital (we ask for you in Book it for me)

What stands out

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Breast MRI

Breast cancer in high-risk women.

Head and neck MRI

Structural detail of the head and neck together in one MRI, for tumors, infection or other soft-tissue abnormalities.

Pelvic MRI

Pelvic organ abnormalities.

Every test, in English

77 tests listed, 47 of them on our shared test list, so they line up against other hospitals' packages.

Liver Function9

Kidney & Electrolytes4

Lipids & Cardiometabolic6

Glucose3

Thyroid & Endocrine3

Tumor Markers5

Infection Serology3

Urine & Stool1

Ultrasound4

CT Imaging2

MRI Imaging5

Bone & Body Composition1

Genetics1

Show all 77 tests and what each screens for

Test	Screens for
Liver Function
Albumin	Liver function and nutrition status.
Alkaline phosphatase	Liver, bile duct and bone conditions.
ALT (SGPT)	Liver cell damage; the most common liver screening test.
AST (SGOT)	Liver cell damage.
Direct bilirubin	Bile duct obstruction.
Gamma-GT	Bile duct and alcohol-related liver stress.
Globulin and A/G ratio	Immune protein levels.
Lipase	Pancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubin	Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen	Kidney function.
Creatinine	Kidney function.
Estimated GFR	Kidney filtering capacity; stages chronic kidney disease.
Uric acid	Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratio	A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterol	Protective cholesterol level.
High-sensitivity CRP	Inflammation linked to heart disease risk.
LDL cholesterol	The main cholesterol driving heart disease risk.
Total cholesterol	Cardiovascular risk.
Triglycerides	Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose	Diabetes and prediabetes.
Hemoglobin A1c	Average blood sugar over the past three months; diabetes.
Fasting insulin	Insulin resistance.
Thyroid & Endocrine
Free T4	Thyroid hormone level.
TSH	Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)	Vitamin D deficiency; bone health.
Tumor Markers
AFP	Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125	Ovarian cancer marker.
CA 19-9	Pancreatic and biliary cancer marker.
CEA	Colorectal and other GI cancer marker.
PSA	Prostate cancer marker.
Infection Serology
Hepatitis B surface antibody	Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody	Hepatitis C infection.
Hepatitis B surface antigen	Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis	Kidney disease, urinary infection, diabetes.
Ultrasound
Abdominal ultrasound	Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound	Breast lumps; complements mammography, especially in dense breasts.
Thyroid ultrasound	Thyroid nodules.
Ultrasound (organ not specified)	An ultrasound whose organ the provider did not specify; confirm before comparing.
CT Imaging
Coronary artery calcium score	Calcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CT	Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Abdominal MRI / MRCP	Liver, pancreas and bile duct tumors and disease.
Breast MRI	Breast cancer in high-risk women.
Head and neck MRI	Structural detail of the head and neck together in one MRI, for tumors, infection or other soft-tissue abnormalities.
Pelvic MRI	Pelvic organ abnormalities.
Whole spine MRI	Whole spine survey.
Bone & Body Composition
Bone density (DXA)	Osteoporosis and fracture risk.
Genetics
Pharmacogenomic panel	How your genes affect drug metabolism.

Liver Function

Albumin

Liver function and nutrition status.

Alkaline phosphatase

Liver, bile duct and bone conditions.

ALT (SGPT)

Liver cell damage; the most common liver screening test.

AST (SGOT)

Liver cell damage.

Direct bilirubin

Bile duct obstruction.

Gamma-GT

Bile duct and alcohol-related liver stress.

Globulin and A/G ratio

Immune protein levels.

Lipase

Pancreatic enzyme; more specific than amylase for pancreatitis.

Total bilirubin

Jaundice, liver and bile problems.

Kidney & Electrolytes

Blood urea nitrogen

Kidney function.

Creatinine

Kidney function.

Estimated GFR

Kidney filtering capacity; stages chronic kidney disease.

Uric acid

Gout risk and kidney stone risk.

Lipids & Cardiometabolic

Total cholesterol / HDL ratio

A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.

HDL cholesterol

Protective cholesterol level.

High-sensitivity CRP

Inflammation linked to heart disease risk.

LDL cholesterol

The main cholesterol driving heart disease risk.

Total cholesterol

Cardiovascular risk.

Triglycerides

Cardiovascular and pancreatitis risk.

Glucose

Fasting glucose

Diabetes and prediabetes.

Hemoglobin A1c

Average blood sugar over the past three months; diabetes.

Fasting insulin

Insulin resistance.

Thyroid & Endocrine

Free T4

Thyroid hormone level.

TSH

Thyroid function; the primary thyroid screening test.

Vitamin D (25-OH)

Vitamin D deficiency; bone health.

Tumor Markers

AFP

Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).

CA-125

Ovarian cancer marker.

CA 19-9

Pancreatic and biliary cancer marker.

CEA

Colorectal and other GI cancer marker.

PSA

Prostate cancer marker.

Infection Serology

Hepatitis B surface antibody

Immunity to hepatitis B (from vaccine or past infection).

Hepatitis C antibody

Hepatitis C infection.

Hepatitis B surface antigen

Current hepatitis B infection; very common in Taiwan.

Urine & Stool

Urinalysis

Kidney disease, urinary infection, diabetes.

Ultrasound

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Thyroid ultrasound

Thyroid nodules.

Ultrasound (organ not specified)

An ultrasound whose organ the provider did not specify; confirm before comparing.

CT Imaging

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

MRI Imaging

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Breast MRI

Breast cancer in high-risk women.

Head and neck MRI

Structural detail of the head and neck together in one MRI, for tumors, infection or other soft-tissue abnormalities.

Pelvic MRI

Pelvic organ abnormalities.

Whole spine MRI

Whole spine survey.

Bone & Body Composition

Bone density (DXA)

Osteoporosis and fracture risk.

Genetics

Pharmacogenomic panel

How your genes affect drug metabolism.

Also listed: Anti-aging test, Autonomic nervous system assessment, Cancer susceptibility genes, Cardiovascular genetic testing, Carotid artery ultrasound, Cerebrovascular MR angiography, contrast-enhanced, Complete blood count with differential, Comprehensive cancer genetic testing, Familial inherited disorders, Fatty liver assessment (ultrasound), Gynecologic and urologic genetic testing, Hepatobiliary and gastrointestinal genetic panel, Immune-related genetic testing, Kidney-related genetic testing, Leukocyte esterase (urine), Liver fibrosis scan (FibroScan), Lung-related genetic testing, Medical history collection, Metabolic pathway analysis genes, Neurological genetic testing, Nutritional genomics testing, Personality trait genomic profiling, Physical trait-related genes, Physiological examination (height, weight, BMI, blood pressure, pulse, respiration, temperature, waist circumference), Small dense LDL (sdLDL), Urine ketones, Urine microscopy, Urine occult blood, Urine pH, Urine specific gravity.

Before you book

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.

Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.

Beitou Health Management Hospital

District hospital

Taipei · Beitou

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

12 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

For general check-in, the center accepts any one of: ID card, National Health Insurance card, driver's license, passport, or resident certificate.
Source ↗ · checked 2026-09-20

Before and on the day

For the standard health checkup, patients must begin fasting, including water and chewing gum, from midnight the night before the checkup.
Source ↗ · checked 2026-09-20
Patients on medication for chronic conditions such as hypertension, cardiovascular disease or diabetes are asked to stop taking them the morning of the checkup (except an asthma inhaler) and to bring the medication to take after all exams are done.
Source ↗ · checked 2026-09-20
Patients who are pregnant or may be pregnant are asked to tell the technicians directly so they can be excluded from X-ray exams and Pap tests.
Source ↗ · checked 2026-09-20
Patients scheduled for an intraocular pressure test are asked not to wear contact lenses on the day of the exam.
Source ↗ · checked 2026-09-20
Patients are asked to bring a stool sample with them to the checkup.
Source ↗ · checked 2026-09-20

Ask your own doctor before changing any medicine.

Results

A specialist physician explains the checkup results one-on-one on the same day.
Source ↗ · checked 2026-09-20
Checkup reports are delivered electronically through the app and by email; a paper copy costs extra.
Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$5,227–5,906 for a woman (43 of 45 tests) and US$4,135–4,824 for a man (41 of 43 tests) (MDsave, Quest and others; checked 2026-10-11).

Executive physicals at top US hospitals ran US$1,700–10,000 (JAMA, 2019).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Abdominal ultrasound: US$150–375, MDsave, ultrasound one body area
AFP: US$50, shayahealth.com (reseller), rough
Hepatitis C antibody: US$62, Quest direct hepatitis C with confirmation
Bone density (DXA): US$150–250, CoveredUSA; primary-md.com
Breast ultrasound (women only): US$331, MDsave Ultrasound Breast Bilateral
CA-125 (women only): US$34, shayahealth.com (reseller), rough
CA 19-9: US$43, shayahealth.com (reseller), rough
CEA: US$28, shayahealth.com (reseller), rough
Coronary artery calcium score: US$100–150, MDsave; GoodRx; Healthline/AHA
Creatinine and 9 related tests, priced as one panel: US$49, Quest direct comprehensive metabolic panel
Direct bilirubin: US$29–39, Walk-In Lab direct bilirubin $29; total + direct $39 (plus $6 physician fee); not sold standalone by Quest or Labcorp, rough
Free T4: US$89, Labcorp OnDemand TSH + free T4 panel $89 list (checked 2026-10-11); Walk-In Lab free T3 + free T4 panel $69 (reseller, not re-checked)
Gamma-GT: US$29–59, Labcorp OnDemand GGT $59; Walk-In Lab $29 (reseller, plus $6 physician fee)
Hemoglobin A1c: US$39, Quest direct
Hepatitis B surface antigen and 1 related test, priced as one panel: US$99, Quest direct hepatitis B with confirmation
High-sensitivity CRP: US$65–69, Quest hs-CRP list $65 ($58.50 promo); Labcorp OnDemand list $69 ($51.75 promo); Walk-In Lab $45 reseller
Fasting insulin: US$34–99, Walk-In Lab fasting insulin $34; Quest Insulin Resistance Test Panel (insulin + C-peptide) $99, rough
Low-dose chest CT: US$99–250, Memorial Healthcare System ($99); AARP (up to $250)
Lipase: US$35–39, Labcorp OnDemand $39; Walk-In Lab $35 reseller
Abdominal MRI / MRCP: US$612, MDsave MRI without contrast (any one body part incl. abdomen)
Breast MRI (women only): US$779, MDsave MRI Breast(s) with and/or without contrast
Pelvic MRI: US$612, MDsave MRI without contrast (any one body part incl. pelvis)
Whole spine MRI: US$1,224, MDsave MRI without contrast x2 (two spine regions), rough
PSA (men only): US$52–62, Quest direct-to-consumer
Thyroid ultrasound: US$220, MDsave Ultrasound (one body area, thyroid listed)
Total cholesterol and 4 related tests, priced as one panel: US$59, Quest direct lipid panel
TSH: US$49, Quest direct
Uric acid: US$42–49, Quest $42 (gout uric acid test); Labcorp OnDemand $49; Walk-In Lab $29 reseller
Urinalysis: US$40–49, Quest $40; Labcorp OnDemand $49; Walk-In Lab $29 reseller
Vitamin D (25-OH): US$75–99, Quest $75; Labcorp OnDemand $99; Walk-In Lab $59 reseller

Radiation from this package's imaging

About 3.2 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.1 years of natural background radiation (about 3 mSv a year, US average).

Not counted: Cerebrovascular MR angiography, contrast-enhanced; Liver fibrosis scan (FibroScan). If it is an X-ray, CT or PET scan, the total is higher.

Bone density (DXA) · about less than 0.01 mSv
Coronary artery calcium score · about 1.7 mSv
Low-dose chest CT · about 1.5 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 21 of these tests

Hepatitis C antibody

Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗

Bone density (DXA)

Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗

Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗

Breast ultrasound

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).

CA-125

Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.

CA 19-9

Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.

Coronary artery calcium score

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.

Fasting glucose

Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.

Free T4

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.

Hemoglobin A1c

Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.

Hepatitis B surface antigen

Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.

HDL cholesterol

Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

High-sensitivity CRP

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.

Low-dose chest CT

Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.

Abdominal MRI / MRCP

Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The USPSTF does not recommend screening the general population for pancreatic cancer by any method; it mentions MRI only as one of the imaging methods studied in people at high risk. The D grade covers the pancreatic-cancer part of an abdominal MRI only, not the liver or bile duct parts of the scan. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.

Breast MRI

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast MRI in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers MRI and ultrasound as supplemental tests; see breast_ultrasound. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion) and does not address MRI screening for those groups.

PSA

Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.

Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.

Thyroid ultrasound

Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗

Total cholesterol

TSH

Urinalysis

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.

Vitamin D (25-OH)

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗

General preparation notes for 14 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal MRI / MRCP

Guidelines on eating vary by center; some ask for a short fast before an abdominal MRI or MRCP. Expect to hold your breath at times during the scan.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.